✦ LIBER ✦

Overexpression of SUMO-1 in hepatocellular carcinoma: a latent target for diagnosis and therapy of hepatoma

✍ Scribed by Wu-hua Guo; Li-hua Yuan; Zhi-hua Xiao; Dan Liu; Ji-xiang Zhang

Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 448 KB
Volume: 137
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-010-0920-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of α-fetoprotein and albumin

Expression of α-fetoprotein and albumin genes in human hepatocellular carcinomas: Limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy

✍ Souhei Ohguchi; Harushige Nakatsukasa; Toshihiro Higashi; Kozo Ashida; Kazuhiro 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 1 views

For an approach of gene therapy for hepatocellular carcinoma (HCC), transcriptional regulatory sequence (TRS) of either alpha-fetoprotein (AFP) or albumin has been used for targeting cancer cells. To examine the feasibility of using TRSs of these genes for possible gene therapy of HCCs, the cellular

Underutilization of therapy for hepatoce

Underutilization of therapy for hepatocellular carcinoma in the medicare population

✍ Shimul A. Shah; Jillian K. Smith; YouFu Li; Sing Chau Ng; James E. Carroll; Jenn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 1 views

## Abstract ## BACKGROUND: The incidence of hepatocellular carcinoma (HCC) is increasing in the United States, and the care of these patients remains highly specialized and complex. Multiple treatment options are available for HCC but their use and effectiveness remain unknown. ## METHODS: Using

Quantitative analysis of hepatoma-specif

Quantitative analysis of hepatoma-specific α-fetoprotein (HS-AFP) by a new mini-column affinity chromatography and its clinical value in diagnosis of hepatocellular carcinoma

✍ Wei Wu; Dengfu Yao; Liwei Qiu; Xiaoxiao Gu; Xinhua Wu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 140 KB

Is there a place for radiation therapy i

Is there a place for radiation therapy in the management of hepatoblastomas and hepatocellular carcinomas in children?

✍ J.-L. Habrand; D. Nehme; C. Kalifa; F. Gauthier; M. Gruner; D. Sarrazin; M.-J. T 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 946 KB

Field-practice study of sorafenib therap

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

✍ Massimo Iavarone; Giuseppe Cabibbo; Fabio Piscaglia; Claudio Zavaglia; Antonio G 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

on behalf of the SOFIA (SOraFenib Italian Assessment) study group A multicenter randomized controlled trial established sorafenib as a standard of care for patients with advanced hepatocellular carcinoma (HCC). Because the study was prematurely interrupted due to survival benefits in the sorafenib a

Overexpression of claudin-3 and claudin-

Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma : Novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE)

✍ Alessandro D. Santin; Stefania Bellone; Moira Marizzoni; Michela Palmieri; Eric 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## Abstract ## BACKGROUND. Uterine serous papillary carcinoma (USPC) represents a highly aggressive variant of endometrial cancer. Using gene expression profiling, we recently identified high expression of the claudin‐3 and claudin‐4 receptors in a limited set of USPC. These tight junction protein